Glenmede Trust’s Vapotherm, Inc. Common Stock VAPO Stock Holding History

Glenmede Trust’s Portfolio VAPO Stock Details VAPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-2	Closed	–	–	2378
2020 Q3	$0	Buy	+2	New	+$576	﹤0.01%	2612

Other funds holding VAPO

PGP

Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return

PGM

Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Hound Partners New York $799M AUM 9.54% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

SPC

Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RVM

RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return

Glenmede Trust's VAPO Position: Q4 2020 in Review

Glenmede Trust sold out of Vapotherm, Inc. Common Stock (VAPO) in Q4 2020, closing a stake of 2 shares.

Glenmede Trust first reported a position in VAPO in Q3 2020 and held it in 1 quarter. The position peaked at $0 in Q3 2020. 109 funds tracked by Wall St. Rank hold VAPO as of Q4 2020.

Glenmede Trust reported no remaining Vapotherm, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Glenmede Trust sold 2 Vapotherm, Inc. Common Stock shares in Q4 2020.
Glenmede Trust first reported a position in Vapotherm, Inc. Common Stock in Q3 2020 and held it in 1 quarter.
Glenmede Trust's Vapotherm, Inc. Common Stock position peaked at $0 in Q3 2020.
109 funds tracked by Wall St. Rank held Vapotherm, Inc. Common Stock as of Q4 2020.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.